[go: up one dir, main page]

AU2001263006A1 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
AU2001263006A1
AU2001263006A1 AU2001263006A AU6300601A AU2001263006A1 AU 2001263006 A1 AU2001263006 A1 AU 2001263006A1 AU 2001263006 A AU2001263006 A AU 2001263006A AU 6300601 A AU6300601 A AU 6300601A AU 2001263006 A1 AU2001263006 A1 AU 2001263006A1
Authority
AU
Australia
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263006A
Inventor
Radoje T Drmanac
Chenghua Liu
Y. Tom Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyseq Inc
Original Assignee
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc filed Critical Hyseq Inc
Publication of AU2001263006A1 publication Critical patent/AU2001263006A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001263006A 2000-05-18 2001-05-16 Novel nucleic acids and polypeptides Abandoned AU2001263006A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57740800A 2000-05-18 2000-05-18
US09/577,408 2000-05-18
PCT/US2001/014827 WO2001088088A2 (en) 2000-05-18 2001-05-16 Novel nucleic acids and polypeptides

Publications (1)

Publication Number Publication Date
AU2001263006A1 true AU2001263006A1 (en) 2001-11-26

Family

ID=24308584

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001263006A Abandoned AU2001263006A1 (en) 2000-05-18 2001-05-16 Novel nucleic acids and polypeptides
AU2001274871A Abandoned AU2001274871A1 (en) 2000-05-18 2001-05-18 Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001274871A Abandoned AU2001274871A1 (en) 2000-05-18 2001-05-18 Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides

Country Status (3)

Country Link
US (1) US20070049743A1 (en)
AU (2) AU2001263006A1 (en)
WO (2) WO2001088088A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100361933B1 (en) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 Chemically defined nonpolymeric bonds form the platform molecule and its conjugate
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
WO2001047950A2 (en) * 1999-12-23 2001-07-05 Universite De Geneve Basolateral sorting signal based on scf peptide and inhibitors thereof
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
US6951939B2 (en) 2000-06-08 2005-10-04 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide
US7504222B2 (en) 2001-10-31 2009-03-17 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DE60220621T2 (en) 2001-11-09 2008-03-06 Proteologics, Inc. Posh nucleic acid, polypeptides and related methods
EP1499635B8 (en) * 2002-05-02 2014-04-16 David Lovejoy Teneurin c-terminal associated peptides (tcap) and uses thereof
US20040081653A1 (en) * 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
US7485297B2 (en) 2003-08-12 2009-02-03 Dyax Corp. Method of inhibition of vascular development using an antibody
JP4723496B2 (en) 2003-09-08 2011-07-13 メルク セローノ ソシエテ アノニム Treatment of fibrotic diseases
US7824685B2 (en) * 2004-01-26 2010-11-02 Baylor College Of Medicine RTVP based compositions and methods for the treatment of prostate cancer
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
ATE498010T1 (en) 2004-03-01 2011-02-15 Immune Disease Inst Inc NATURAL IGM ANTIBODIES AND INHIBITORS THEREOF
US20090239793A1 (en) * 2004-09-24 2009-09-24 Isabella Caniggia Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover
CA2611054C (en) * 2005-06-17 2017-05-09 National Research Council Of Canada Novel a.beta.-binding polypeptides and derivatives and uses thereof
JP2007063225A (en) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd Imidazopyridine compound
JP5302012B2 (en) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド Glucokinase activator
JP5386350B2 (en) 2006-05-31 2014-01-15 タケダ カリフォルニア インコーポレイテッド Indazole and isoindole derivatives as glucokinase activators
JP5419706B2 (en) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド Glucokinase activator
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
JP5931336B2 (en) 2007-07-02 2016-06-08 オンコメッド ファーマシューティカルズ インコーポレイテッド Compositions and methods for treating and diagnosing cancer
EP2384440B1 (en) * 2009-01-02 2015-08-12 Flysun Development Co. Ltd Synthetic peptides, methods and kits for diagnosing autoimmune diseases
US8465756B2 (en) * 2009-08-12 2013-06-18 National Health Research Institutes Immunogenic peptides of tumor associated antigen L6 and uses thereof in cancer therapy
CN103313723B (en) * 2009-12-16 2015-02-04 荷兰联合利华有限公司 Peptide
TWI398262B (en) * 2010-07-29 2013-06-11 Nat Health Research Institutes Immunogenic peptides of tumor associated antigen l6 and uses thereof in cancer therapy
US9409987B2 (en) * 2011-04-15 2016-08-09 Compugen Ltd Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
CN106167526A (en) 2011-07-15 2016-11-30 昂考梅德药品有限公司 RSPO bonding agent and its application
WO2013176623A1 (en) * 2012-05-21 2013-11-28 Agency For Science, Technology And Research (A*Star) Inhibitors for the treatment of cancer
CA2878868A1 (en) 2012-07-13 2014-01-16 Austin L. Gurney Rspo3 binding agents and uses thereof
US9409977B2 (en) 2013-03-12 2016-08-09 Decimmune Therapeutics, Inc. Humanized, anti-N2 antibodies
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3193935A4 (en) 2014-09-16 2018-03-21 Oncomed Pharmaceuticals, Inc. Treatment of fibrotic diseases
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3093043B1 (en) 2015-05-13 2018-11-14 Brainsgate Ltd. Implant and delivery system for neural stimulator
JP7449092B2 (en) 2017-01-30 2024-03-13 ナショナル リサーチ カウンシル オブ カナダ Blood-brain barrier migration compounds and their uses
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140056A (en) * 1999-01-27 2000-10-31 Millennium Pharmaceuticals, Inc. MSP-18 protein and nucleic acid molecules and uses therefor

Also Published As

Publication number Publication date
AU2001274871A1 (en) 2001-11-26
WO2001088092A3 (en) 2002-03-07
US20070049743A1 (en) 2007-03-01
WO2001088092A2 (en) 2001-11-22
WO2001088088A2 (en) 2001-11-22
WO2001088088A3 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2002343417A1 (en) Novel nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
WO2002016439A8 (en) Novel nucleic acids and polypeptides
AU2001239889A1 (en) Polypeptides and nucleic acids encoding same
AU3511100A (en) Novel nucleic acids and polypeptides
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2001263005A1 (en) Novel nucleic acids and polypeptides
AU2001256977A1 (en) Human sez6 nucleic acids and polypeptides
AU2001252926A1 (en) Novel nucleic acids and polypeptides